Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Utilization of a deoxynucleoside diphosphate substrate by HIV reverse transcriptase

Garforth, SJ and Parniak, MA and Prasad, VR (2008) Utilization of a deoxynucleoside diphosphate substrate by HIV reverse transcriptase. PLoS ONE, 3 (4).

Published Version
Available under License : See the attached license file.

Download (666kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Background: Deoxynucleoside triphosphates (dNTPs) are the normal substrates for DNA sysnthesis is catalyzed by polymerases such as HIV-1 reverse transcriptase (RT). However, substantial amounts of deoxynucleoside diphosphates (dNDPs) are also present in the cell. Use of dNDPs in HIV-1 DNA sysnthesis could have significant implications for the efficacy of nucleoside RT inhibitors such as AZT which are first line therapeutics fro treatment of HIV infection. Our earlier work on HIV-1 reverse transcriptase (RT) suggested that the interaction between the γ phosphate of the incoming dNTP and RT residue K65 in the active site is not essential for dNTP insertion, implying that this polymerase may be able to insert dNPs in addition to dNTPs. Methodology/Principal Findings: We examined the ability of recombinant wild type (wt) and mutant RTs with substitutions at residue K65 to utilize a dNDP substrate in primer extension reactions. We found that wild type HIV-1 RT indeed catalyzes incorporation of dNDP substrates whereas RT with mutations of residue K645 were unable to catalyze this reaction. Wild type HIV-1 RT also catalyzed the reverse reaction, inorganic phosphate-dependent phosphorolysis. Nucleotide-mediated phosphorolytic removal of chain-terminating 3′-terminal nucleoside inhibitors such as AZT forms the basis of HIV-1 resistance to such drugs, and this removal is enhanced by thymidine analog mutations (TAMs). We found that both wt and TAM-containing RTs were able to catalyze Pi-mediated phosphorolysis of 3′-terminal AZT at physiological levels of Pi with an efficacy similar to that for ATP-dependent AZT-excision. Conclusion: We have identified two new catalytic function of HIV-1 RT, the use of dNDPs as substrates for DNA synthesis, and the use of Pi as substrate for phosphorolytic removal of primer 3′-terminal nucleotides. The ability to insert dNDPs has been documented for only one other DNA polymerase The RB69 DNA polymerase and the reverse reaction employing inorganic phosphate has not been documented for any DNA polymerase. Importantly, our results show that Pi-mediated phosphorolysis can contribute to AZT resistance and indicates that factors that influence HIV resistance to AZT are more complex than previously appreciated. © 2008 Garforth et al.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Garforth, SJ
Parniak, MAmap167@pitt.eduMAP167
Prasad, VR
ContributionContributors NameEmailPitt UsernameORCID
Date: 30 April 2008
Date Type: Publication
Journal or Publication Title: PLoS ONE
Volume: 3
Number: 4
DOI or Unique Handle: 10.1371/journal.pone.0002074
Schools and Programs: School of Medicine > Biochemistry and Molecular Genetics
Refereed: Yes
PubMed ID: 18446195
Date Deposited: 18 Jul 2012 20:44
Last Modified: 05 Feb 2019 11:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item